IL6 and ovarian carcinoma: Inflammatory molecules such as IL-6, IL-8, IL-1β, and TNF-α have been shown to contribute to senescence and cancer initiation and progression in multiple cancers including breast and colorectal cancers [22, 23], and IL-6 is a therapeutic target in ovarian cancer [24, 25].